HI

Hikma Pharmaceuticals PLCLSE Hikma Pharmaceuticals Stock Report

Last reporting period 31 Dec, 2023

Updated 01 Nov, 2024

Last price

Market cap $B

5.52

Middle

Exchange

XLON - London Stock Exchange

View Full Company Analysis

Return on assets ROA

4 %

Last period ROA

-4%

ROA has decreased in 5 years


What is ROA ?

The return on assets ratio shows how much net income a company earns per unit of assets.

What is ROA ?

The return on assets ratio shows how much net income a company earns per unit of assets.

What is ROA of Hikma Pharmaceuticals ?

Hikma Pharmaceuticals`s ROA for the last twelve months ended 2023-12-31 is 4 %

View Full Company Analysis